Dr. Pepper Snapple Group, Inc. (NYSE: DPS) is up about 150% from the lows of 2009.  This weekend Barron’s came out with a very bullish article.  We called for this to have a higher dividend, and Barron’s called for some thinking the stock can go over $40.00.

AthenaHealth, Inc. (NASDAQ: ATHN) is on deck for earnings on Monday after the closing bell.  Be advised that we have not confirmed this release due to its recent earnings delay along with its annual report delay.  Thomson Reuters has estimates at $0.17 EPS on just over $55 million.  At $38 and change, shares have held up rather well considering its delayed 10-K and it telegraphing that earnings restatements were likely.  Its 52-week trading range is $23.15 to $47.82.  Due to the recent changes, this one will be a wait- and-see for many traders and investors.  For whatever it is worth, the open interest here is leaning toward the PUTS over CALLS by more than 2-to-1.

Sequenom In.c (NASDAQ: SQNM) is also on deck for earnings after the close on Monday.  While this one is down over the last five sessions, Sequenom has exhibited a stellar return from its lows with gains of 200% or more.  We are not looking at estimates here because the withdrawn Down’s Syndrome test has marked that largely irrelevant.  The company’s last cash balance with securities included was over $65 million.  The company may have some of its woes behind it, but calling the ball here may be alchemy rather than science.

More junk!  AMBAC Financial (NYSE: ABK) is on deck Tuesday.  The earnings estimate is -$3.34 from Thomson Reuters.  The stock tried to make a run with the other financial junk-trunk stocks but has given back gains.  Based on other municipal insurance reports, interest here may be increased.  It is still hard to imagine how this one will avoid meeting the hangman.

Nike Inc. (NYSE: NKE) is up for earnings on Wednesday and Thomson Reuters has estimates of $0.88 EPS and $4.59 billion.  This would compare to $0.99 EPS a year ago but on a 3% sales gain.  Go ahead and expect the first question to be about Tiger Woods…. that was the case at Nike’s last quarterly conference call Q&A from analysts.